Skip to main content
SpringerLink
Log in

Peginterferon and Dose-Titrated Ribavirin for Hepatitis C-Associated Nephrotic Membranoproliferative Glomerulonephritis Type 1

  • Case Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Johnson RJ, Gretch DR, Yamabe H, et al.: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465–470, 1993

    Article  PubMed  Google Scholar 

  2. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002—-June 10–12, 2002. Hepatology 36:S3–S20, 2002

    Google Scholar 

  3. Strader DB, Wright T, Thomas DL, Seeff LB: Diagnosis, management, and treatment of hepatitis C. Hepatology 39:1147–1171, 2004

    Article  PubMed  Google Scholar 

  4. Fabrizi F, Poordad FF, Martin P: Hepatitis C infection and the patient with end-stage renal disease. Hepatology 36:3–10, 2002

    Article  PubMed  Google Scholar 

  5. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ: Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347:103–109, 2002

    Article  PubMed  Google Scholar 

  6. Cruzado JM: Recurrent glomerulonephritis and risk of renal allograft loss. N Engl J Med 347:1531–1532 (discussion 1531–1532), 2002

    Google Scholar 

  7. Kramer P, ten Kate FW, Bijnen AB, Jeekel J, Weimar W: Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients. Lancet 1:989–990, 1984

    Article  PubMed  Google Scholar 

  8. Glue P: The clinical pharmacology of ribavirin. Semin Liver Dis 19 (Suppl 1):17–24, 1999

    PubMed  Google Scholar 

  9. Bruchfeld A, Stahle L, Andersson J, Schvarcz R: Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection—-a pilot study. J Viral Hepat 8:287–292, 2001

    Article  PubMed  Google Scholar 

  10. Tan AC, Brouwer JT, Glue P, et al.: Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study. Nephrol Dial Transplant 16:193–195, 2001

    Article  PubMed  Google Scholar 

  11. Bruchfeld A, Lindahl K, Schvarcz R, Stahle L: Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysis. Ther Drug Monit 24:701–708, 2002

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology and Hepatology, Sint Jan Hospital, Brugge, Belgium

    Hans Orlent MD

  2. Departments of Hospital Pharmacy and Clinical Pharmacology, Erasmus Medical Center, Rotterdam, the Netherlands

    Ron A. Mathot MD & Arnold G. Vulto MD

  3. Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands

    Eric F. Van Bommel MD

  4. Departments of Hepatology and Gastroenterology, Erasmus Medical Center, Rotterdam, the Netherlands

    Solko W. Schalm MD, PhD

  5. Department of Hepatology and Gastroenterology, Reinier de Graaf Hospital Group, Delft, the Netherlands

    Johannes T. Brouwer MD

  6. Department of Gastroenterology and Hepatology, AZ Sint Jan, Ruddershove 10, 8000, Brugge, Belgium

    Hans Orlent MD

Authors
  1. Hans Orlent MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ron A. Mathot MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eric F. Van Bommel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arnold G. Vulto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Solko W. Schalm MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Johannes T. Brouwer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans Orlent MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Orlent, H., Mathot, R.A., Van Bommel, E.F. et al. Peginterferon and Dose-Titrated Ribavirin for Hepatitis C-Associated Nephrotic Membranoproliferative Glomerulonephritis Type 1. Dig Dis Sci 50, 1804–1806 (2005). https://doi.org/10.1007/s10620-005-2941-x

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-005-2941-x

Key Words

Search

Navigation